Johnson & Johnson

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Johnson & Johnson
Nov 13, 2024, 10:52 | Blog
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO/DARZALEX…
Jul 7, 2024, 18:19 | Insight
Shahrin Ahmed: Efficacy of CARVYKTI in multiple myeloma
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "The Phase III…
Jun 21, 2024, 13:43 | Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Mar 11, 2024, 00:11 | Career
Mary Kate Weber: I've stepped into the role of Associate Director, Patient and Caregiver Solutions - Oncology within the PECS organization at Johnson & Johnson!
Mary Kate Weber, Associate Director, Patient & Caregiver Solutions - Oncology at Johnson & Johnson,…
Nov 9, 2023, 18:59 | Drugs
Najat Khan: Lots of buzz about the future of drug discovery
Najat Khan, Chief Data Science Officer & SVP/Global Head at Johnson & Johnson, made the…
Oct 7, 2023, 19:42 | Blog
Najat Khan: The results of the world’s largest blood biomarker study have been published in Nature, opening up new possibilities for scientific research.
Najat Khan, Chief Data Science Officer & SVP/Global Head, Strategy, Portfolio, Ops, R&D, J&J at…
Sep 15, 2023, 18:40 | Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
All: 7 Posts: 1 - 100
Special Coverage